ADHD：儿童和青少年注意缺陷多动障碍的诊断、评估和治疗的临床实践指南。
ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.
出版信息
Pediatrics. 2011 Nov;128(5):1007-22. doi: 10.1542/peds.2011-2654. Epub 2011 Oct 16.
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is the most common neurobehavioral disorder of childhood and can profoundly affect the academic achievement, well-being, and social interactions of children; the American Academy of Pediatrics first published clinical recommendations for the diagnosis and evaluation of ADHD in children in 2000; recommendations for treatment followed in 2001.
摘要
注意缺陷多动障碍（ADHD）是儿童最常见的神经行为障碍，可深刻影响儿童的学业成就、幸福感和社会交往；美国儿科学会于 2000 年首次发布了儿童 ADHD 的诊断和评估临床建议；2001 年又发布了治疗建议。
相似文献
1
ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.ADHD：儿童和青少年注意缺陷多动障碍的诊断、评估和治疗的临床实践指南。
Pediatrics. 2011 Nov;128(5):1007-22. doi: 10.1542/peds.2011-2654. Epub 2011 Oct 16.
2
Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.儿童和青少年注意缺陷多动障碍的诊断、评估和治疗临床实践指南。
Pediatrics. 2019 Oct;144(4). doi: 10.1542/peds.2019-2528.
3
A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.一个就注意力缺陷/多动障碍的诊断和管理达成社区共识的过程。
Pediatrics. 2005 Jan;115(1):e97-104. doi: 10.1542/peds.2004-0953.
4
Preschool ADHD Diagnosis and Stimulant Use Before and After the 2011 AAP Practice Guideline.2011年美国儿科学会实践指南前后的学龄前注意力缺陷多动障碍诊断与兴奋剂使用情况
Pediatrics. 2016 Dec;138(6). doi: 10.1542/peds.2016-2025. Epub 2016 Nov 15.
5
6
Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.新发注意力缺陷/多动障碍的药物治疗：实践模式与质量指标
Curr Med Res Opin. 2014 Aug;30(8):1687-99. doi: 10.1185/03007995.2014.905461. Epub 2014 Apr 7.
7
Treatment of Attention-Deficit/Hyperactivity Disorder in Preschool-Age Children: Child and Adolescent Psychiatrists' Adherence to Clinical Practice Guidelines.学龄前儿童注意力缺陷/多动障碍的治疗：儿童和青少年精神科医生对临床实践指南的遵循情况
J Child Adolesc Psychopharmacol. 2016 May;26(4):335-43. doi: 10.1089/cap.2015.0108. Epub 2016 Apr 22.
8
Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.儿童及青少年注意力缺陷/多动障碍的诊断与治疗。美国医学协会科学事务委员会。
JAMA. 1998 Apr 8;279(14):1100-7. doi: 10.1001/jama.279.14.1100.
9
A planned care approach and patient registry to improve adherence to clinical guidelines for the diagnosis and management of attention-deficit/hyperactivity disorder.一种旨在提高对注意力缺陷多动障碍诊断和管理临床指南依从性的计划式护理方法及患者登记系统。
Acad Pediatr. 2015 May-Jun;15(3):289-96. doi: 10.1016/j.acap.2014.12.002.
10
Receipt of Medication and Behavioral Therapy Among a National Sample of School-Age Children Diagnosed With Attention-Deficit/Hyperactivity Disorder.全国范围内确诊患有注意缺陷多动障碍的学龄儿童药物治疗和行为疗法的接受情况。
Acad Pediatr. 2018 Apr;18(3):256-265. doi: 10.1016/j.acap.2017.10.003. Epub 2017 Oct 20.
引用本文的文献
1
ADHD Diagnosis and Timing of Medication Initiation Among Children Aged 3 to 5 Years.3至5岁儿童的注意力缺陷多动障碍诊断及药物治疗起始时间
JAMA Netw Open. 2025 Aug 1;8(8):e2529610. doi: 10.1001/jamanetworkopen.2025.29610.
2
Global trends in physical activity research of attention-deficit/hyperactivity disorder: A scientometric study (2000-2024).注意缺陷多动障碍体育活动研究的全球趋势：一项科学计量学研究（2000 - 2024年）
Medicine (Baltimore). 2025 Aug 15;104(33):e43794. doi: 10.1097/MD.0000000000043794.
3
Separable but Correlated: The Role of Executive Functions and Effortful Control in the Transition to School Age.可分离但相关：执行功能和努力控制在进入学龄期过渡中的作用。
Behav Sci (Basel). 2025 Jun 23;15(7):845. doi: 10.3390/bs15070845.
4
Assessment of Attention-Deficit/Hyperactivity Disorder in Young Autistic Children.幼儿自闭症患者注意力缺陷/多动障碍的评估
J Clin Child Adolesc Psychol. 2025 Jul 9:1-14. doi: 10.1080/15374416.2025.2521856.
5
Impact of COVID-19 pandemic policies on ADHD medication prescriptions among children and adolescents in Portugal.新冠疫情政策对葡萄牙儿童和青少年多动症药物处方的影响。
Eur J Pediatr. 2025 Jun 12;184(7):415. doi: 10.1007/s00431-025-06229-y.
6
Timing of Medication Treatment in Children 3-5-Years-old with ADHD: A PEDSnet Study.3至5岁多动症儿童药物治疗的时机：一项儿科电子数据网络（PEDSnet）研究
medRxiv. 2025 May 29:2025.05.28.25328526. doi: 10.1101/2025.05.28.25328526.
7
Evaluating the effectiveness of the complementary therapy web application based on Kiddo game therapy on children with attention deficit hyperactivity disorder: a before and after study.评估基于儿童游戏疗法的辅助治疗网络应用程序对注意力缺陷多动障碍儿童的有效性：一项前后对照研究。
BMC Pediatr. 2025 Mar 28;25(1):247. doi: 10.1186/s12887-025-05607-7.
8
Cardiological Findings in Children and Adolescents Before and After Guanfacine Treatment for Attention Deficit and Hyperactivity Disorder.胍法辛治疗儿童及青少年注意力缺陷多动障碍前后的心脏学检查结果
Children (Basel). 2025 Feb 27;12(3):302. doi: 10.3390/children12030302.
9
The Sleep Train Program: Efficacy of a Behavioral Sleep Intervention for Children with Externalizing Problems.睡眠训练计划：针对外化问题儿童的行为睡眠干预的效果
Behav Sleep Med. 2025 Feb 20:1-17. doi: 10.1080/15402002.2025.2467159.
10
Risky behaviours and injuries amongst Catalan children with ADHD: does pharmacological treatment improve outcomes?加泰罗尼亚多动症儿童的危险行为与伤害：药物治疗能否改善预后？
Health Econ Rev. 2025 Feb 8;15(1):7. doi: 10.1186/s13561-025-00595-x.
本文引用的文献
1
A double-blind, placebo-controlled study of atomoxetine in young children with ADHD.一项关于阿托西汀治疗注意缺陷多动障碍（ADHD）儿童的双盲、安慰剂对照研究。
Pediatrics. 2011 Apr;127(4):e862-8. doi: 10.1542/peds.2010-0825. Epub 2011 Mar 21.
2
Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder.可乐定控释片治疗注意缺陷多动障碍儿科患者。
J Am Acad Child Adolesc Psychiatry. 2011 Feb;50(2):171-9. doi: 10.1016/j.jaac.2010.11.005.
3
Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children --- United States, 2003 and 2007.儿童注意缺陷多动障碍报告发病率增加——美国，2003 年和 2007 年。
MMWR Morb Mortal Wkly Rep. 2010 Nov 12;59(44):1439-43.
4
Enhancing pediatric mental health care: report from the American Academy of Pediatrics Task Force on Mental Health. Introduction.加强儿童心理健康护理：美国儿科学会心理健康特别工作组报告。引言。
Pediatrics. 2010 Jun;125 Suppl 3:S69-74. doi: 10.1542/peds.2010-0788C.
5
Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents and young adults using the general practice research database.注意缺陷多动障碍（ADHD）药物治疗相关的死亡率：一项使用全科医学研究数据库对儿童、青少年和青年进行的回顾性队列研究。
Drug Saf. 2009;32(11):1089-96. doi: 10.2165/11317630-000000000-00000.
6
Sudden death and use of stimulant medications in youths.青少年猝死与刺激性药物的使用
Am J Psychiatry. 2009 Sep;166(9):992-1001. doi: 10.1176/appi.ajp.2009.09040472. Epub 2009 Jun 15.
7
Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.盐酸胍法辛缓释片治疗儿童及青少年注意力缺陷多动障碍的长期安全性和有效性
J Child Adolesc Psychopharmacol. 2009 Jun;19(3):215-26. doi: 10.1089/cap.2008.0080.
8
Predicting attention-deficit/hyperactivity disorder and oppositional defiant disorder from preschool diagnostic assessments.从学前诊断评估预测注意力缺陷/多动障碍和对立违抗性障碍
J Consult Clin Psychol. 2009 Apr;77(2):349-54. doi: 10.1037/a0014638.
9
Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD.盐酸胍法辛缓释片用于儿童和青少年注意力缺陷多动障碍的长期开放标签扩展研究。
CNS Spectr. 2008 Dec;13(12):1047-55. doi: 10.1017/s1092852900017107.
10
Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children.儿童使用注意力缺陷多动障碍药物相关的幻觉及其他精神病性症状。
Pediatrics. 2009 Feb;123(2):611-6. doi: 10.1542/peds.2008-0185.
Zotero 插件